Signal transduction of interleukin 2 in human natural killer cells: involvement of the p56lck tyrosine kinase
- PMID: 7910947
- DOI: 10.1016/0161-5890(94)90170-8
Signal transduction of interleukin 2 in human natural killer cells: involvement of the p56lck tyrosine kinase
Abstract
Despite numerous reports, the role of the protein tyrosine kinase p56lck in IL-2 signal transduction has remained controversial. We show here, using IL-2-dependent human natural killer cell lines, that p56lck is regulated by IL-2 in two different ways: (1) IL-2 induces a rapid increase of p56lck kinase activity as assessed in vitro; and (2) following IL-2 stimulation, p56lck undergoes phosphorylation on serine residues that is reflected by a modification of its electrophoretic mobility in SDS-PAGE. Furthermore, dose response experiments, and blocking studies performed with anti-IL-2R alpha antibodies, indicated that binding of IL-2 to the IL-2R beta chain was sufficient to produce these modifications of p56lck. In contrast, activation of the CD2 pathway stimulated the kinase activity of p56lck, but did not induce a significant shift in NK cells, as opposed to T lymphocytes. Western blot analyses, and immunoprecipitations of cell lysates from 32P-preloaded NK cells demonstrated that seven major proteins are tyrosine phosphorylated in response to IL-2. These phosphoproteins, with apparent molecular weights of 190, 150, 120, 110, 85, 65 and 56, which may not all be p56lck substrates, undergo phosphorylation and dephosphorylation with different kinetics. Furthermore, pp120 was identified as rasGAP, by Western blot and immunoprecipitation experiments. rasGAP and some of its co-precipitating molecules become phosphorylated in response to IL-2, presumably by p56lck, which would thus provide a link between IL-2R and downstream events critical for NK cell proliferation and function.
Similar articles
-
Interleukin-2 signal transduction in human NK cells: multisite phosphorylation and activation of the tyrosine kinase p56lck.J Leukoc Biol. 1992 Nov;52(5):565-71. doi: 10.1002/jlb.52.5.565. J Leukoc Biol. 1992. PMID: 1385559
-
Protein tyrosine phosphorylation and p56lck modification in IL-2 or phorbol ester-activated human natural killer cells.J Immunol. 1990 Sep 1;145(5):1490-7. J Immunol. 1990. PMID: 1696599
-
Genistein, a tyrosine kinase inhibitor, decreased the affinity of p56lck to beta-chain of interleukin-2 receptor in human natural killer (NK)-rich cells and decreased NK-mediated cytotoxicity.Proc Soc Exp Biol Med. 1994 Nov;207(2):227-33. doi: 10.3181/00379727-207-43811. Proc Soc Exp Biol Med. 1994. PMID: 7938054
-
P56lck A lymphocyte specific protein tyrosine kinase: activation, regulation and signal transduction.Cell Mol Biol (Noisy-le-grand). 1994 Jul;40(5):605-9. Cell Mol Biol (Noisy-le-grand). 1994. PMID: 7981618 Review.
-
T-lymphocyte proliferation: tyrosine kinases in interleukin 2 signal transduction.Baillieres Clin Haematol. 1992 Jul;5(3):551-73. doi: 10.1016/s0950-3536(11)80007-7. Baillieres Clin Haematol. 1992. PMID: 1457964 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources